Headlands Technologies’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Headlands Technologies's NVS Position: Q2 2026 in Review
Headlands Technologies increased its Novartis (NVS) stake by 262% in Q2 2026, buying an estimated $775K and bringing the position to 7,145 shares worth $1.12M. The position accounts for 0.12% of the portfolio, ranked #214.
Headlands Technologies first reported a position in NVS in Q4 2022 and has held it in 4 quarters since. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Headlands Technologies held 7,145 shares of Novartis worth $1.12M as of Q2 2026.
- Headlands Technologies bought 5,172 Novartis shares in Q2 2026, an estimated $775K.
- Novartis made up 0.12% of Headlands Technologies's portfolio in Q2 2026, its #214 holding.
- Headlands Technologies first reported a position in Novartis in Q4 2022 and has held it in 4 quarters since.
- 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.